FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gary Rogers

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Concepts & Ideas

Kinetics

Co-author Network

Publications

TOP 3
Robert E Hampson; R A España; Gary A Rogers; Linda J Porrino; Sam A Deadwyler
Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717.
Christopher S Rex; Julie C Lauterborn; Ching-Yi Lin; Enikö A Kramár; Gary A Rogers; Christine M Gall; Gary Lynch
Restoration of long-term potentiation in middle-aged hippocampus after induction of brain-derived neurotrophic factor.
Linda J Porrino; James B Daunais; Gary A Rogers; Robert E Hampson; Sam A Deadwyler
Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gary Rogers (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Robert E Hampson; R A España; Gary A Rogers; Linda J Porrino; Sam A Deadwyler
Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717.
Psychopharmacology 2009;202(1-3):355-69.
2006: Christopher S Rex; Julie C Lauterborn; Ching-Yi Lin; Enikö A Kramár; Gary A Rogers; Christine M Gall; Gary Lynch
Restoration of long-term potentiation in middle-aged hippocampus after induction of brain-derived neurotrophic factor.
Journal of neurophysiology 2006;96(2):677-85.
2005: Linda J Porrino; James B Daunais; Gary A Rogers; Robert E Hampson; Sam A Deadwyler
Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates.
PLoS biology 2005;3(9):e299.
2003: Myung-Hee Kim; Mei Lu; Gary A Rogers; Stanley Parsons; Louis B Hersh
Specificity of the rat vesicular acetylcholine transporter.
Neurochemical research 2003;28(3-4):473-6.
2002: Munirathinam Subramani; Gary A Rogers; Ben A Bahr
Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors elicits neuroprotection after trimethyltin exposure in hippocampus.
Toxicology and applied pharmacology 2002;185(2):111-8.
2002: Amy C Arai; Yan-Fang Xia; Gary A Rogers; Gary Lynch; Markus Kessler
Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action.
The Journal of pharmacology and experimental therapeutics 2002;303(3):1075-85.
2002: Ben A Bahr; Jennifer Bendiske; Queenie B Brown; Munirathinam Subramani; Ebru Caba; Markus Rudin; Stephan Urwyler; André Sauter; Gary A Rogers
Survival signaling and selective neuroprotection through glutamatergic transmission.
Experimental neurology 2002;174(1):37-47.
2001: Vishnu Suppiramaniam; Ben A Bahr; Srikumar Sinnarajah; K Owens; Gary A Rogers; Solomon Yilma; Vitaly Vodyanoy
Member of the Ampakine class of memory enhancers prolongs the single channel open time of reconstituted AMPA receptors.
Synapse (New York, N.Y.) 2001;40(2):154-8.
2000: Amy C Arai; Markus Kessler; Gary A Rogers; Gary Lynch
Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466.
Molecular pharmacology 2000;58(4):802-13.
2000: Mitsuru Haniu; Paul E Denis; Yunjen Young; E A Mendiaz; J Fuller; JO Hui; BD Bennett; S Kahn; S Ross; TL Burgess; V Katta; Gary A Rogers; Robert Vassar; Martin Citron
Characterization of Alzheimer's beta -secretase protein BACE. A pepsin family member with unusual properties.
The Journal of biological chemistry 2000;275(28):21099-106.
2000: Markus Kessler; Gary A Rogers; A Arai
The norbornenyl moiety of cyclothiazide determines the preference for flip-flop variants of AMPA receptor subunits.
Neuroscience letters 2000;287(2):161-5.
1999: S A Johnson; N T Luu; T A Herbst; R Knapp; D Lutz; A Arai; Gary A Rogers; G Lynch
Synergistic interactions between ampakines and antipsychotic drugs.
The Journal of pharmacology and experimental therapeutics 1999;289(1):392-7.
1998: Robert E Hampson; Gary A Rogers; G Lynch; Sam A Deadwyler
Facilitative effects of the ampakine CX516 on short-term memory in rats: correlations with hippocampal neuronal activity.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998;18(7):2748-63.
1998: Robert E Hampson; Gary A Rogers; G Lynch; Sam A Deadwyler
Facilitative effects of the ampakine CX516 on short-term memory in rats: enhancement of delayed-nonmatch-to-sample performance.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998;18(7):2740-7.
1998: Markus Kessler; M S Mutneja; Gary A Rogers; Gary Lynch
Regional preferences of AMPA receptor modulators determined through agonist binding autoradiography.
Brain research 1998;783(1):121-6.
1998: Stanley M Parsons; Gary A Rogers; L M Gracz
Photoaffinity labeling of vesicular acetylcholine transporter from electric organ of Torpedo.
Methods in enzymology 1998;296():99-116.
1997: M Ingvar; J Ambros-Ingerson; M Davis; Richard Granger; Markus Kessler; Gary A Rogers; R S Schehr; Gary Lynch
Enhancement by an ampakine of memory encoding in humans.
Experimental neurology 1997;146(2):553-9.
1997: L C Palmer; US Hess; John Larson; Gary A Rogers; Christine M Gall; Gary Lynch
Comparison of the effects of an ampakine with those of methamphetamine on aggregate neuronal activity in cortex versus striatum.
Brain research. Molecular brain research 1997;46(1-2):127-35.
1997: M Hennegriff; A Arai; Markus Kessler; P Vanderklish; M S Mutneja; Gary A Rogers; R L Neve; Gary Lynch
Stable expression of recombinant AMPA receptor subunits: binding affinities and effects of allosteric modulators.
Journal of neurochemistry 1997;68(6):2424-34.
1996: John Larson; C N Quach; B Q LeDuc; A Nguyen; Gary A Rogers; Gary Lynch
Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats.
Brain research 1996;738(2):353-6.
1996: A Arai; Markus Kessler; J Ambros-Ingerson; A Quan; E Yigiter; Gary A Rogers; Gary Lynch
Effects of a centrally active benzoylpyrrolidine drug on AMPA receptor kinetics.
Neuroscience 1996;75(2):573-85.
1996: J Sirvio; John Larson; C N Quach; Gary A Rogers; Gary Lynch
Effects of pharmacologically facilitating glutamatergic transmission in the trisynaptic intrahippocampal circuit.
Neuroscience 1996;74(4):1025-35.
1996: A Arai; Markus Kessler; Gary A Rogers; Gary Lynch
Effects of a memory-enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus.
The Journal of pharmacology and experimental therapeutics 1996;278(2):627-38.
1996: Richard Granger; S Deadwyler; M Davis; B Moskovitz; Markus Kessler; Gary A Rogers; Gary Lynch
Facilitation of glutamate receptors reverses an age-associated memory impairment in rats.
Synapse (New York, N.Y.) 1996;22(4):332-7.
1996: Gary Lynch; Markus Kessler; Gary A Rogers; J Ambros-Ingerson; Richard Granger; R S Schehr
Psychological effects of a drug that facilitates brain AMPA receptors.
International clinical psychopharmacology 1996;11(1):13-9.
1995: John Larson; T Lieu; V Petchpradub; B LeDuc; H Ngo; Gary A Rogers; Gary Lynch
Facilitation of olfactory learning by a modulator of AMPA receptors.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1995;15(12):8023-30.
1995: Tracey J Shors; R J Servatius; R F Thompson; Gary A Rogers; G Lynch
Enhanced glutamatergic neurotransmission facilitates classical conditioning in the freely moving rat.
Neuroscience letters 1995;186(2-3):153-6.
1994: Ursula Stäubli; Y Perez; F B Xu; Gary A Rogers; M Ingvar; S Stone-Elander; Gary Lynch
Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(23):11158-62.
1994: A Arai; Markus Kessler; P Xiao; J Ambros-Ingerson; Gary A Rogers; Gary Lynch
A centrally active drug that modulates AMPA receptor gated currents.
Brain research 1994;638(1-2):343-6.
1994: Gary A Rogers; Sharon Stone-Elander; Martin Ingvar; L Eriksson; Stanley M Parsons; L Widén
18F-labelled vesamicol derivatives: syntheses and preliminary in vivo small animal positron emission tomography evaluation.
Nuclear medicine and biology 1994;21(2):219-30.
1994: UV Staubli; Gary A Rogers; Gary Lynch
Facilitation of glutamate receptors enhances memory.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(2):777-81.
1993: Richard Granger; UV Staubli; M Davis; Y Perez; L Nilsson; Gary A Rogers; Gary Lynch
A drug that facilitates glutamatergic transmission reduces exploratory activity and improves performance in a learning-dependent task.
Synapse (New York, N.Y.) 1993;15(4):326-9.
1993: Martin Ingvar; Sharon Stone-Elander; Gary A Rogers; B Johansson; L Eriksson; Stanley M Parsons; L Widén
Striatal D2/acetylcholine interactions: PET studies of the vesamicol receptor.
Neuroreport 1993;4(12):1311-4.
1993: Gary A Rogers; W D Kornreich; K Hand; Stanley M Parsons
Kinetic and equilibrium characterization of vesamicol receptor-ligand complexes with picomolar dissociation constants.
Molecular pharmacology 1993;44(3):633-41.
1993: Gary A Rogers; Stanley M Parsons
Photoaffinity labeling of the vesamicol receptor of cholinergic synaptic vesicles.
Biochemistry 1993;32(33):8596-601.
1993: Stanley M Parsons; B A Bahr; Gary A Rogers; E D Clarkson; K Noremberg; B W Hicks
Acetylcholine transporter--vesamicol receptor pharmacology and structure.
Progress in brain research 1993;98():175-81.
1992: E D Clarkson; Gary A Rogers; Stanley M Parsons
Binding and active transport of large analogues of acetylcholine by cholinergic synaptic vesicles in vitro.
Journal of neurochemistry 1992;59(2):695-700.
1992: B A Bahr; K Noremberg; Gary A Rogers; B W Hicks; Stanley M Parsons
Linkage of the acetylcholine transporter-vesamicol receptor to proteoglycan in synaptic vesicles.
Biochemistry 1992;31(25):5778-84.
1992: Gary A Rogers; Stanley M Parsons
Photoaffinity labeling of the acetylcholine transporter.
Biochemistry 1992;31(25):5770-7.
1992: B A Bahr; E D Clarkson; Gary A Rogers; K Noremberg; Stanley M Parsons
A kinetic and allosteric model for the acetylcholine transporter-vesamicol receptor in synaptic vesicles.
Biochemistry 1992;31(25):5752-62.
1992: L Widén; L Eriksson; Martin Ingvar; Stanley M Parsons; Gary A Rogers; Sharon Stone-Elander
Positron emission tomographic studies of central cholinergic nerve terminals.
Neuroscience letters 1992;136(1):1-4.
1991: Martin Ingvar; L Eriksson; Gary A Rogers; Sharon Stone-Elander; L Widén
Rapid feasibility studies of tracers for positron emission tomography: high-resolution PET in small animals with kinetic analysis.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1991;11(6):926-31.
1991: B W Hicks; Gary A Rogers; Stanley M Parsons
Purification and characterization of a nonvesicular vesamicol-binding protein from electric organ and demonstration of a related protein in mammalian brain.
Journal of neurochemistry 1991;57(2):509-19.
1990: Gary A Rogers; Stanley M Parsons
Persistent occultation of the vesamicol receptor.
Neuroreport 1990;1(1):22-5.
1989: R Kaufman; Gary A Rogers; C Fehlmann; Stanley M Parsons
Fractional vesamicol receptor occupancy and acetylcholine active transport inhibition in synaptic vesicles.
Molecular pharmacology 1989;36(3):452-8.
1989: Gary A Rogers; Stanley M Parsons
Inhibition of acetylcholine storage by acetylcholine analogs in vitro.
Molecular pharmacology 1989;36(2):333-41.
1989: Gary A Rogers; Stanley M Parsons; D C Anderson; L M Nilsson; B A Bahr; W D Kornreich; R Kaufman; Robert S Jacobs; B Kirtman
Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogues of trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol).
Journal of medicinal chemistry 1989;32(6):1217-30.
1987: Stanley M Parsons; B A Bahr; L M Gracz; R Kaufman; W D Kornreich; L Nilsson; Gary A Rogers
Acetylcholine transport: fundamental properties and effects of pharmacologic agents.
Annals of the New York Academy of Sciences 1987;493():220-33.
1977: Gary A Rogers
A tritium exchange method for characterization of modified histidyl residues and its application to fumarase.
Analytical biochemistry 1977;78(2):406-9.
1976: Gary A Rogers; N Shaltiel; Paul D Boyer
Facile alkylation of methionine by benzyl bromide and demonstration of fumarase inactivation accompanied by alkylation of a methionine residue.
The Journal of biological chemistry 1976;251(18):5711-7.
1974: Gary A Rogers; T C Bruice
Synthesis and evaluation of a model for the so-called "charge-relay" system of the serine esterases.
Journal of the American Chemical Society 1974;96(8):2473-81.